Our Impact brand
For people in underserved communities, one of the largest barriers to treatment is the persistent lack of access to medicine.
Our Impact brand is helping close this gap by making a portfolio of Sanofi quality medicines available at accessible prices across the countries where need is greatest and where Sanofi has little to no presence. With a primary focus on NCDs, Impact brand medicines are now available in 32 countries.
Our Impact brand’s reach continues to grow. Since its launch in 2022, more than 201,600 patients have been treated with Impact brand medicines, illustrating that when pricing and availability barriers come down, access to quality care becomes possible for those who need it most.
201,600+ patients treated with Impact brand medicines
32 countries supplied with Impact brand medicines
Two pharmacists walking through the hallway of the pharmacy at the CNSS hospital in Djibouti City